Skip to main content
Log in

Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Thirty-one evaluable adults with recurrent astrocytomas were treated with Cisplatin 35 Mg/ M2 I.V. daily for three days every 3–4 weeks. All patients had previously been irradiated and most had previously received chemotherapy. Approximately half had poor performance status. Two patients experienced complete remissions and two additional patients experienced partial remissions. Three patients stabilized. Gastrointestinal toxicity was generally mild. Further studies are planned of Cisplatin in combination with other agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rozencweig M, Von Hoff DD, Slavik M, Muggia F: Cis-diamminedichloroplatinum: A new anticancer drug. Ann Intern Med 86:803–812, 1977.

    Google Scholar 

  2. Khan A, McCullough D, Borts F, Sinks LF: Update on use of cisplatinum in CNS malignancies. Proc Am Assoc Cancer Res 21:390, 1980.

    Google Scholar 

  3. Stewart DJ, Wallace S, Feun L, Leavens M, Young SE, Handel S, Mavligit G, Benjamin RS: Phase I study of intracarotid artery infusion of cis-diamminedichloroplatinum (II) in patients with recurrent malignant intracerebral tumors. Cancer Res 42:2059–2062, 1982.

    Google Scholar 

  4. Stewart DJ, Leavens M, Maor M, Feun L, Luna M, Bonura J, Caprioli R, Loo TL, Benjamin RS: Human central nervous system distribution of cis-diammined ichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 42:2474–2479, 1982.

    Google Scholar 

  5. Stewart DJ, Feun L, Maor M, Leavens M, Burgess MA, Benjamin RS, Bodey GP Sr: Weekly Cisplatin during cranial irradiation for malignant melanoma metastatic to brain. J Neuro-Oncol 1:49–51, 1983.

    Google Scholar 

  6. Stewart DJ, Benjamin RS, Luna M, Seifert WE, Loo TL: Human tissue distribution of platinum after cis-diamminedichloroplatinum. Cancer Chemother Pharmacol 10:51–54, 1982.

    Google Scholar 

  7. Drewinko B, Gottlieb JA: Action of cis-diammined ichloroplatinum (II) (NSC-119875) at the cellular level. Cancer Chemother Rep 59:665–673, 1975.

    Google Scholar 

  8. Stewart DJ: Intra-arterial drug administration. In: Rosenblum M, Wilson C (eds) Progress in experimental tumor research, Vol 2. S Harger Medical and, Scientific Publishers, Basel (in press).

  9. Stewart DJ, Benjamin RS, Zimmerman S, Caprioli RM, Wallace S, Chuang V, Calvo III D, Samuels M, Bonura J, Loo TL: Clinical pharmacology of intra-arterial cis-diammine dichloroplatinum. Cancer Res 43: 917–920, 1983.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stewart, D.J., O'Bryan, R.M., Al-Sarraf, M. et al. Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study. J Neuro-Oncol 1, 145–147 (1983). https://doi.org/10.1007/BF00182960

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00182960

Keywords

Navigation